CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 231 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62,894,893 | +25.4% | 2,307,344 | +2.3% | 0.02% | +31.2% |
| Q2 2023 | $50,158,736 | +7.5% | 2,254,466 | +4.7% | 0.02% | 0.0% |
| Q1 2023 | $46,655,756 | +110043.7% | 2,154,007 | +3.3% | 0.02% | +23.1% |
| Q4 2022 | $42,359 | -99.9% | 2,085,625 | -0.9% | 0.01% | -38.1% |
| Q3 2022 | $53,959,000 | +8.7% | 2,104,483 | +0.8% | 0.02% | +16.7% |
| Q2 2022 | $49,648,000 | +13.6% | 2,087,672 | +7.6% | 0.02% | +38.5% |
| Q1 2022 | $43,716,000 | +17.2% | 1,940,826 | +3.0% | 0.01% | +18.2% |
| Q4 2021 | $37,291,000 | -27.1% | 1,883,466 | -27.5% | 0.01% | -31.2% |
| Q3 2021 | $51,163,000 | -16.7% | 2,599,645 | -6.9% | 0.02% | -15.8% |
| Q2 2021 | $61,429,000 | -1.1% | 2,792,179 | +6.9% | 0.02% | -9.5% |
| Q1 2021 | $62,097,000 | -7.6% | 2,612,484 | +1.7% | 0.02% | -12.5% |
| Q4 2020 | $67,180,000 | +48.5% | 2,568,052 | -1.2% | 0.02% | +26.3% |
| Q3 2020 | $45,240,000 | +2.6% | 2,599,243 | -0.8% | 0.02% | 0.0% |
| Q2 2020 | $44,091,000 | +44.3% | 2,621,369 | +2.0% | 0.02% | +18.8% |
| Q1 2020 | $30,563,000 | -0.2% | 2,570,610 | +1.6% | 0.02% | +45.5% |
| Q4 2019 | $30,613,000 | -15.0% | 2,530,017 | -0.7% | 0.01% | -21.4% |
| Q3 2019 | $36,027,000 | +28.7% | 2,548,687 | +1.5% | 0.01% | +27.3% |
| Q2 2019 | $27,986,000 | +3.3% | 2,509,912 | +8.8% | 0.01% | 0.0% |
| Q1 2019 | $27,080,000 | +6.5% | 2,306,735 | +21.2% | 0.01% | -8.3% |
| Q4 2018 | $25,424,000 | +1.7% | 1,903,036 | +6.8% | 0.01% | +20.0% |
| Q3 2018 | $24,987,000 | -3.9% | 1,782,278 | +7.8% | 0.01% | 0.0% |
| Q2 2018 | $25,999,000 | +0.2% | 1,653,862 | +4.9% | 0.01% | -9.1% |
| Q1 2018 | $25,936,000 | +13.1% | 1,576,649 | +24.1% | 0.01% | +10.0% |
| Q4 2017 | $22,936,000 | -1.3% | 1,269,958 | +5.4% | 0.01% | 0.0% |
| Q3 2017 | $23,242,000 | +131.9% | 1,204,325 | +41.8% | 0.01% | +100.0% |
| Q2 2017 | $10,022,000 | +97.5% | 849,319 | +83.5% | 0.01% | +150.0% |
| Q1 2017 | $5,074,000 | +572.1% | 462,888 | +345.1% | 0.00% | – |
| Q4 2016 | $755,000 | +1506.4% | 104,003 | +932.7% | 0.00% | – |
| Q1 2016 | $47,000 | -90.5% | 10,071 | -89.9% | 0.00% | – |
| Q4 2015 | $494,000 | -57.0% | 99,292 | -67.5% | 0.00% | -100.0% |
| Q3 2015 | $1,150,000 | -48.1% | 305,900 | -17.0% | 0.00% | 0.0% |
| Q2 2015 | $2,216,000 | +7.3% | 368,679 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $2,065,000 | +79.7% | 368,679 | -3.7% | 0.00% | 0.0% |
| Q4 2014 | $1,149,000 | +12.0% | 382,907 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $1,026,000 | -4.3% | 382,907 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,072,000 | -36.5% | 382,907 | -1.2% | 0.00% | 0.0% |
| Q1 2014 | $1,689,000 | +35.4% | 387,407 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $1,247,000 | +100.2% | 387,407 | -1.1% | 0.00% | 0.0% |
| Q3 2013 | $623,000 | -8.0% | 391,607 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $677,000 | – | 391,607 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,825,262 | $138,621 | 7.54% |
| Novo Holdings A/S | 3,377,768 | $68,602,468 | 4.28% |
| Parallel Advisors, LLC | 3,724,664 | $75,647,926 | 3.28% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $722 | 2.29% |
| Quantedge Capital Pte Ltd | 251,312 | $5,104,147 | 1.71% |
| S&T BANK/PA | 346,306 | $7,033 | 1.30% |
| Freshford Capital Management, LLC | 249,000 | $5,057,190 | 1.09% |
| Birchview Capital, LP | 50,000 | $1,016 | 0.72% |
| FAS Wealth Partners, Inc. | 306,276 | $6,220,466 | 0.70% |
| Bridge City Capital, LLC | 60,824 | $1,235 | 0.63% |